Germany Chromatography Columns Market

ID: MRFR/HC/49846-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026
Germany Chromatography Columns Market Research Report: Size, Share, Trend Analysis By Column Type (Normal Phase Chromatography Columns, Pre-Packed Chromatography Columns, Automated Chromatography Columns), By Chromatography Type (Ion Exchange Chromatography, Affinity Chromatography, Gas chromatography, Gel Filtration Chromatography, Others), By Applications (Anion and Cation Exchange, Sample Preparation, Resin Screening, Protein Purification, Desalting) and By End Users (Research Institutes, Pharmaceutical Biotechnology Companies, Food & Beverage Manufacturers, Others) - Growth Outlook & Industry Forecast 2025 To 2035
Germany Chromatography Columns Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.67%
2024 Market Size$ 1,200 Million
2025 Market Size$ 1,268.04 Million
2035 Market Size$ 2,200 Million
Key Players
Agilent Technologies
Thermo Fisher Scientific
Waters Corporation
Merck KGaA
PerkinElmer
Shimadzu Corporation
Trends
  • Technological Advancements
  • Sustainability Initiatives
  • Regulatory Compliance
Opportunities
  • Growing Environmental Concerns
  • Rising Demand in Pharmaceutical Sector
  • Increased Research Activities in Academia
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Column Type (USD Million)
      1. 4.1.1 Normal Phase Chromatography Columns
      2. 4.1.2 Prepacked Chromatography Columns
      3. 4.1.3 Automated Chromatography Columns
    2. 4.2 Life Sciences, BY Chromatography Type (USD Million)
      1. 4.2.1 Ion Exchange Chromatography
      2. 4.2.2 Affinity Chromatography
      3. 4.2.3 Gas Chromatography
      4. 4.2.4 Size Exclusion Chromatography
    3. 4.3 Life Sciences, BY Application (USD Million)
      1. 4.3.1 Anion & Cation Exchange
      2. 4.3.2 Sample Preparation
      3. 4.3.3 Resin Screening
      4. 4.3.4 Protein Purification
      5. 4.3.5 Desalting
    4. 4.4 Life Sciences, BY End User (USD Million)
      1. 4.4.1 Research Institutes
      2. 4.4.2 Pharmaceutical Biotechnology Companies
      3. 4.4.3 Food & Beverage Manufacturers
      4. 4.4.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Agilent Technologies (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Thermo Fisher Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Waters Corporation (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Merck KGaA (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 PerkinElmer (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Shimadzu Corporation (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Sartorius AG (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Bio-Rad Laboratories (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Jasco Corporation (JP)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GERMANY MARKET ANALYSIS BY COLUMN TYPE
    3. 6.3 GERMANY MARKET ANALYSIS BY CHROMATOGRAPHY TYPE
    4. 6.4 GERMANY MARKET ANALYSIS BY APPLICATION
    5. 6.5 GERMANY MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
    9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    12. 6.12 LIFE SCIENCES, BY COLUMN TYPE, 2024 (% SHARE)
    13. 6.13 LIFE SCIENCES, BY COLUMN TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 LIFE SCIENCES, BY CHROMATOGRAPHY TYPE, 2024 (% SHARE)
    15. 6.15 LIFE SCIENCES, BY CHROMATOGRAPHY TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
    17. 6.17 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
    18. 6.18 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
    19. 6.19 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY COLUMN TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Germany Life Sciences Market Segmentation

Life Sciences By Column Type (USD Million, 2025-2035)

  • Normal Phase Chromatography Columns
  • Prepacked Chromatography Columns
  • Automated Chromatography Columns

Life Sciences By Chromatography Type (USD Million, 2025-2035)

  • Ion Exchange Chromatography
  • Affinity Chromatography
  • Gas Chromatography
  • Size Exclusion Chromatography

Life Sciences By Application (USD Million, 2025-2035)

  • Anion & Cation Exchange
  • Sample Preparation
  • Resin Screening
  • Protein Purification
  • Desalting

Life Sciences By End User (USD Million, 2025-2035)

  • Research Institutes
  • Germany Chromatography Columns Market Biotechnology Companies
  • Food & Beverage Manufacturers
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.